Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride InChi: InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h8-10

InChi: InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h8-10

of SNI-2011 reached to Cmax within 1 h in both species

ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1

Smiles: CC(=O)O[C@]12[C@H]3[C@@H](OC(=O)C4C=CC=CC=4)[C@](O)(C[C@H]3[C@]34[C@H]5C(OC)[C@H]1[C@H]3N(C[C@]5(COC)[C@H](O)C[C@@H]4OC)CC)[C@@H](OC)[C@@H]2O

Isoprenaline (300 nM

Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride InChi: InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h8-10Valacyclovir, also known as valacyclovir, is an antiviral drug used in the management of herpes simplex, herpes zoster (shingles), and herpes B. It is a prodrug, being converted in vivo to aciclovir. Valaciclovir has been available as a generic drug in the U. S. since November 25, 2009. Valaciclovir is a prodrug, an esterified version of aciclovir that has greater oral bioavailability (about 55%) than aciclovir (1020%). It is converted by esterases to